LiverDiseaseNASHFibrosisModel.PDFVIP

Liver Disease NASH/Fibrosis Model Please contact: Dipti Deshpande PhD ddeshpande@ or Carol Gebert PhD cgebert@ 617-513-5280 Liver Diseases Comprise a Growing Market NAFLD: 10-20% of Americans may suffer undiagnosed. NASH: Estimated to affect 2-5% of Americans. Cirrhosis: Approx. 25% of NASH patients progress. Liver Cancer: Third highest cancer mortality, globally. Mouse Non Alcoholic Steatohepatitis (NASH) Model: 1. Pancr